SCHEMBL8889137

SCHEMBL8889137

O=C(O)NC(=O)Cc1c[nH]c2ccccc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.65
ALDH1A1 P00352 5/20 0.65
SMN1; SMN2 Q16637 3/20 0.65
MEN1 O00255 3/20 0.65
KMT2A Q03164 3/20 0.65
KDM4E B2RXH2 2/20 0.65
HPGD P15428 1/20 0.65
SLC6A2 P23975 1/20 0.61
FNTA P49354 1/20 0.61
FNTB P49356 1/20 0.61
LMNA P02545 3/20 0.60
PKM P14618 3/20 0.58
GAA P10253 3/20 0.58
STAT3 P40763 1/20 0.56
RAB9A P51151 1/20 0.56
HSD17B10 Q99714 1/20 0.56
CYP1A2 P05177 1/20 0.56
POLB P06746 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1519724 0.84 MAPT (0.64) MAPTALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL7807900 0.83 HRH3 (0.67) MAPTALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL31218207 0.83 HRH3 (0.67) MAPTALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL1853622 0.83 LMNA (0.71) MAPTALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL947150 0.83 MAPT (0.73) MAPTALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL7976825 0.83 SMN1; SMN2 (0.71) MAPTALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL5803900 0.83 MAPT (0.62) MAPTALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL1395865 0.83 MAPT (0.62) MAPTALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL468296 0.82 LMNA (0.65) MAPTALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL29411993 0.82 LMNA (0.65) MAPTALDH1A1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5643903-A PSYCOLOGICAL DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-07-01 US disclosed
EP-0481254-B1 2-(4-Piperidinyl)-1H-pyrido[4,3-b]indol-1 ones and related compounds, intermediates and a process for their preparation HOECHST ROUSSEL PHARMA (US) 1995-12-27 EP disclosed
US-5430038-A Antipsychotic agents HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1995-07-04 US disclosed
US-5430154-A 2-(4-piperidinyl)-1H-pyrido[4,3-b]-indol-1-ones and related compounds HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1995-07-04 US disclosed
US-5292883-A Antipsychotics HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1994-03-08 US disclosed
US-5229517-A Intermediates for antipsychotic agents HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-07-20 US disclosed
EP-0481254-A2 2-(4-Piperidinyl)-1H-pyrido[4,3-b]indol-1 ones and related compounds, intermediates and a process for their preparation HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-04-22 EP disclosed
US-5102889-A For treating psychosis HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-04-07 US disclosed